SearcharxivSearch

arXiv subjects

Maximin Lange

Publications and source records attributed to Maximin Lange.

3 recordsLinked to original sources

Towards a Deterministic Math Solver for Clinical Language Models

Large language models are unreliable at arithmetic, which is a problem for clinical calculators where a single numerical error changes the recommendation. The standard response is to hardcode each calculator as a validated function, one at a time. We test an alternative: the model does not calculate. Instead, it writes case-specific Python that a restricted local executor runs as a deterministic solver, and the model's task reduces to deciding how to use it. We evaluate this Program-Solve interface on MedCalc-Bench Verified (1,100 cases, 55 calculators) against direct model arithmetic and a hand-written 22-calculator library, using Qwen2.5-7B and Qwen2.5-32B-AWQ, after auditing the benchmark's formulas against current clinical guidelines and flagging 16 of 55 with version, use or coefficient concerns. With formulas and gold variables supplied and both routes reading the whole note, handing off to the solver is not a reliable advantage at 7B (75.31% against 72.02%, a paired +3.29 points with a 95% calculator-cluster interval of [-3.49, 10.38]) but is one at 32B (90.53% against 83.47%, +7.05 [0.47, 14.60], clear of zero). The hand-written library is exact on its 440 supported cases but abstains elsewhere (40.0% overall). Adding an executor thus helps some open-weight models more than others even under matched formula, variable and note access, and is not a substitute for verified formulas or reliable variable extraction either way.

cs.AI

Agents Catching Agents: Shortcut Cascades and Benchmark Gaming in Clinical Multi-Agent Systems

Clinical decision support is moving toward committees of language-model agents deliberating on a shared workspace. We ask whether such committees can be gamed by shortcuts, cues a benchmark rewards but a clinician would ignore. Across seven cohorts on six public datasets spanning text (MedQA-USMLE, MedMCQA, MIMIC-CXR reports), imaging (NIH ChestX-ray14, MIMIC-CXR-JPG, CheXpert) and tabular ICU records (SUPPORT2), Gemini committees resist these cues in isolation (flip 5-16%), yet a socially plausible shortcut spreads: when two peers assert the same wrong answer, the holdout under test adopts it in 38% of cases, as does a false "pre-screen" system flag, on both capability tiers. Of three oversight agents, a gate cannot separate adoption from honest agreement (false-positive rate 100%); a same-lineage judge reading only the transcript flags adoption on text (precision 100%, recall 93%) but collapses onto the gate in imaging; a referee that privately re-queries the holdout transfers to imaging (77-88% precision, 13-21% false-positive rate). Tripling a cue's visual salience does not move contagion, whereas a second peer voice raises it by half again. Gaming a hidden rubric is near-silent: only 1/10 text and 1/134 imaging drifters name the rubric they moved toward. What games a committee is social plausibility, and only a referee independent of self-report catches it. Code: https://github.com/criticaldata/benchmaxxing

cs.AI

Beyond Ethics: How Inclusive Innovation Drives Economic Returns in Medical AI

While ethical arguments for fairness in healthcare AI are well-established, the economic and strategic value of inclusive design remains underexplored. This perspective introduces the ``inclusive innovation dividend'' -- the counterintuitive principle that solutions engineered for diverse, constrained use cases generate superior economic returns in broader markets. Drawing from assistive technologies that evolved into billion-dollar mainstream industries, we demonstrate how inclusive healthcare AI development creates business value beyond compliance requirements. We identify four mechanisms through which inclusive innovation drives returns: (1) market expansion via geographic scalability and trust acceleration; (2) risk mitigation through reduced remediation costs and litigation exposure; (3) performance dividends from superior generalization and reduced technical debt, and (4) competitive advantages in talent acquisition and clinical adoption. We present the Healthcare AI Inclusive Innovation Framework (HAIIF), a practical scoring system that enables organizations to evaluate AI investments based on their potential to capture these benefits. HAIIF provides structured guidance for resource allocation, transforming fairness and inclusivity from regulatory checkboxes into sources of strategic differentiation. Our findings suggest that organizations investing incrementally in inclusive design can achieve expanded market reach and sustained competitive advantages, while those treating these considerations as overhead face compounding disadvantages as network effects and data advantages accrue to early movers.

cs.AI